Loading...
Loading...
Application UK00917987352 · Registered
| Application Number | UK00917987352 |
| Status | Registered |
| Owner | Immudex ApS |
| Filed | 2018-11-20 |
| Registered | 2019-04-17 |
| Renewal Due | 2028-11-20 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. dCODE Dextramer is currently a registered UK trademark, with renewal due on 2028-11-20. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Chemicals used in diagnostics, industry and science; diagnostic reagents for diagnostic (other than medical and veterinary) and scientific purposes; research reagents for scientific and diagnostic purposes; diagnostic test materials for scientific and diagnostic (other than medical and veterinary) purposes; diagnostic kits for scientific and diagnostic (other than medical and veterinary) purposes; assays for research and diagnostic (other than medical and veterinary) purposes; biochemical reagents (other than medical and veterinary); preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB-vaccines, HIV-vaccines, CMV-vaccines and other vaccines; or for use in connection with therapy and immunotherapy, including cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; chemical reagents for other than medicinal and veterinary purposes.
Preparations for pharmaceutical purposes; preparations for medical purposes; chemical-pharmaceutical preparations; diagnostic preparations for medical purposes; reagents for medical and veterinary purposes; vaccines; preparations for analysis for medical purposes, hereunder for each of the abovementioned preparations for development or analysis of vaccines, immunotherapeutics and cellular therapies, including cancer vaccines and immunotherapeutics, borrelia vaccines, TB-vaccines, HIV-vaccines and CMV-vaccines, T-cell therapies; or for use in connection with cancer therapy or other therapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for infectious diseases, and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring.
'dCODE Dextramer' is a registered trademark on the UK IPO register, owned by Immudex ApS. The application (UK00917987352) was filed on 20 November 2018 and registered on 17 April 2019. The registration is set to expire on 20 November 2028.
This mark is recorded under multiple classes: Class 1 (chemicals for industrial, scientific & agricultural use); Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by Kilburn & Strode LLP.
UK trademark UK00917987352 for the mark 'dCODE Dextramer' in Class 1, 5 is recorded on the UK IPO register as owned by Immudex ApS. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00917987352 for the mark 'dCODE Dextramer' as registered.
UK trademark UK00917987352 for the mark 'dCODE Dextramer' is recorded in Class 1 (chemicals for industrial, scientific & agricultural use); Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 1: Chemicals used in diagnostics, industry and science; diagnostic reagents for diagnostic (other than medical and veterinary) and scientific purposes; research reagents for scientific and diagnostic purposes; diagnostic test materials for scientific and diagnostic (other than medical and veterinary) purposes;…
UK trademark UK00917987352 for the mark 'dCODE Dextramer' was filed at the UK IPO on 20 November 2018 and registered on 17 April 2019.
UK trademark UK00917987352 for the mark 'dCODE Dextramer' is currently recorded as valid until 20 November 2028, at which point it will need to be renewed with the UK IPO to remain in force.
Kilburn & Strode LLP is listed as the attorney / representative of record for UK trademark UK00917987352 for the mark 'dCODE Dextramer' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.